KLI

First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP-ribose) Polymerase-1 Inhibitor, JPI-289, in Healthy Volunteers

Metadata Downloads
Publisher
DRUG DESIGN DEVELOPMENT AND THERAPY
Language
영어
ISSN
1177-8881
Citation Volume
14
Citation Start Page
3189
Citation End Page
3199
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.